Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-22

Clinical Trial Update: Atovaquone Combined With Radiation in Children With Malignant Brain Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating atovaquone in combination with radiation for pediatric malignant brain tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atovaquone (Atovaquone)

Snippet

Sponsor: Emory University | Conditions: High-grade Glioma, Medulloblastoma | Phase 1 | Status: RECRUITING